4‐Phenylbutyrate promoted wild‐type γ‐aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2+/Q390X mice associated with Dravet syndrome is a research paper published in Epilepsia (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: R01 082635
National Institute of Neurological Disorders and Stroke
Grant: R01 NS121718
NINDS NIH HHS
Grant: R01 NS082635
NICHD NIH HHS
Grant: P50 HD103537
National Institutes of Health
Grant: 5R01NS121718-03
Promoting Protein Trafficking with 4-phenylbutyrate to Treat Genetic Epilepsy
Citizens United for Research in Epilepsy
Dravet Syndrome Foundation
FWCI
1.57
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals